| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Hamilton Thomas Edward is a Director at Larimar Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 8 buys and 1 sell.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | LRMR Larimar Therapeutics, Inc. | Director | Buy | 100,000 | $5.00 | $500,000.00 | +17.7% | - | - | |
| Feb 16, 2024 | LRMR Larimar Therapeutics, Inc. | Director | Buy | 57,208 | $8.74 | $499,997.92 | +11.3% | -41.9% | -73.9% | |
| Sep 16, 2022 | LRMR Larimar Therapeutics, Inc. | Director | Buy | 317,460 | $3.15 | $999,999.00 | +167.0% | +42.5% | +32.5% | |
| Jun 30, 2021 | LRMR Larimar Therapeutics, Inc. | Director | Buy | 56,710 | $8.75 | $496,212.50 | +42.5% | +24.7% | -80.0% | |
| May 3, 2021 | NLY Annaly Capital Management Inc | Director | Sell | 80,000 | $9.18 | $734,432.00 | -100% | -5.3% | -18.9% | |
| May 15, 2020 | NLY Annaly Capital Management Inc | Director | Buy | 200,000 | $5.96 | $1,192,920.00 | +153.8% | - | - | |
| May 17, 2019 | NLY Annaly Capital Management Inc | Director | Buy | 90,000 | $9.47 | $852,294.00 | +36.0% | - | - |